Ladenburg Thalmann & Co. Inc. Issues Pessimistic Forecast for QT Imaging (NASDAQ:QTI) Stock Price

QT Imaging (NASDAQ:QTI) had its target price lowered by Ladenburg Thalmann & Co. Inc. to $12.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Ladenburg Thalmann & Co. Inc.‘s price objective indicates a potential upside of 465.24% from the company’s previous close.

Other analysts have also recently issued research reports about the stock. D. Boral Capital initiated coverage on shares of QT Imaging in a research report on Friday, October 23rd. They set a “buy” rating and a $9.00 target price for the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of QT Imaging in a report on Tuesday, October 6th. Finally, Craig Hallum assumed coverage on QT Imaging in a research note on Monday, October 5th. They set a “buy” rating and a $8.00 target price for the company. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $9.67.

QT Imaging Price Performance

NASDAQ QTI traded down $0.14 during trading hours on Wednesday, reaching $2.12. 71,025 shares of the company’s stock were exchanged, compared to its average volume of 41,254. QT Imaging has a one year low of $1.96 and a one year high of $7.60. The firm has a fifty day moving average of $2.47 and a 200-day moving average of $4.34. The stock has a market cap of $29.23 million, a PE ratio of -1.29 and a beta of 0.05. The company has a current ratio of 3.10, a quick ratio of 2.06 and a debt-to-equity ratio of 6.81.

QT Imaging (NASDAQ:QTI) last released its quarterly earnings results on Tuesday, November 10th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.07. The business had revenue of $7.34 million for the quarter, compared to analysts’ expectations of $10.79 million. QT Imaging had a negative net margin of 77.25% and a negative return on equity of 1,202.69%. On average, equities research analysts predict that QT Imaging will post -1.11 earnings per share for the current fiscal year.

Institutional Trading of QT Imaging

Hedge funds have recently made changes to their positions in the business. Stonepine Capital Management LLC acquired a new position in shares of QT Imaging during the 2nd quarter worth approximately $407,000. Polar Asset Management Partners Inc. acquired a new stake in QT Imaging during the 2nd quarter valued at $210,000. Finally, BlackRock Inc. lifted its holdings in QT Imaging by 116.5% during the 2nd quarter. BlackRock Inc. now owns 61,353 shares of the company’s stock valued at $250,000 after purchasing an additional 33,009 shares during the last quarter. 24.19% of the stock is owned by institutional investors and hedge funds.

QT Imaging Company Profile

QT Imaging Holdings, Inc. (NASDAQ:QTI) is a medical technology company that develops advanced ultrasound-based imaging systems. Its technology is designed to create three-dimensional images of human tissue without using ionizing radiation. The company’s principal product is the QTscan, an automated breast-imaging system that uses sound waves to capture images without breast compression. The system is intended to support breast imaging and may be particularly relevant for evaluating breast tissue that can be difficult to assess with conventional mammography.